Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Mid Cap

Corona Remedies Share Price

Corona Remedies Ltd.

₹1,500

-41.00(-2.66%)

Trade Now

2nd Apr 2026 | 3:28 PM

NSE : CORONA

Open Free Demat Account

Corona Remedies Performance

Price Movement

₹1500.00

₹1485.50

₹1568.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1500.00

₹1336.60

₹1699.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,568.00

Low₹1,485.50

Open at₹1,541.00

Prev Close₹1,541.00

Volumes30.61 K

Avg Price₹1,508.79

Lower Circuit₹1,232.80

Upper Circuit₹1,849.20

Historical Performance

3M High₹1,699.00

3M Low₹1,363.90

1 Yr High₹1,699.00

1 Yr Low₹1,336.60

3 Yr High₹1,699.00

3 Yr Low₹1,336.60

5 Yr High₹1,699.00

5 Yr Low₹1,336.60

Corona Remedies Fundamentals

Market Cap

High in industry

9,169.10 Cr.

PE Ratio (TTM)

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

30.9% incr over last year

24.64

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

High in industry

13.10

MFI

MFI is mid-range

44.82

RSI

RSI is mid-range

45.35

EPS (TTM)

24.43

Debt to Equity

0.10

Face Value

Operating Profit Margin Qtr.

19.96

Operating Profit Qtr.

83.16

Net Profit Qtr.

41.27

Operating Revenue Qtr.

342.42

PB Ratio

13.10

Corona Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Dec 2024	Sep 2024
Total Revenue	342.42	361.13	346.54	297.69	313.87
Operating Expense	259.26	282.66	276.76	228.27	247.05
Operating Profit	83.16	78.47	69.78	69.42	66.82
Depreciation	9.45	9.20	8.92	9.69	9.05
Interest	1.66	1.93	1.99	2.39	2.87
Tax	13.94	17.46	14.49	13.33	14.38
Net Profit	41.25	52.15	46.40	44.77	42.98

Corona Remedies Technicals

Corona Remedies Ltd. EMA & SMA

₹1500.00

-41.00 (-2.66%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1565

Day EMA10 ₹1575.5

Day EMA12 ₹1577.2

Day EMA20 ₹1577.4

Day EMA26 ₹1573.3

Day EMA50 ₹1537.9

Corona Remedies Support and Resistance

Resistance

First Resistance₹1592.93

Second Resistance₹1644.87

Third Resistance₹1677.93

Support

First Support₹1507.93

Second Support₹1474.87

Third Support₹1422.93

Technical Indicators

Day RSI45.35

Day MFI44.82

Day ADX13.67

Day Commodity Channel Index-67.60

William-80.00

Day MACD3.92

Day MACD Signal Line12.17

Day ATR62.64

Day ROC125-

Day ROC21-4.43

Corona Remedies Shareholding Pattern

Held By	Dec 2025
Promoter	69
FII	1.8
DII	6.8
Public	22.4

Corona Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	9.77 K	22.87 K	42.69%
Week	19.84 K	32.94 K	60.25%
1 Month	21.38 K	38.62 K	55.37%
6 Month	67.03 K	2.13 L	31.54%

Corona Remedies SWOT Analysis

Strengths10

Weakness7

Opportunity3

Threats1

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Corona Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Corona Remedies Stock Comparison

Financials	Sudeep Pharma Ltd.	Rubicon Research Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹615	₹775	₹1,395	₹4,578	₹496.65
% Change	0.16%	-0.91%	-2.88%	0.93%	0.04%
Revenue TTM (₹ Cr)	-	₹1,598.19	₹1,419.33	₹878.40	₹4,256.70
Net Profit TTM (₹ Cr)	-	₹206.20	₹20.10	₹240.10	₹318.19
PE TTM	-	62.00	800.80	43.90	24.70
1 Year Return	3.73	59.76	-13.79	-4.8	5.55
ROCE	34.78	34.76	3.26	-	11.27

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 355.30

+1.23%

CONCORDBIO

Concord Biotech Ltd.

₹ 1025.00

+0.49%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 642.00

+1.09%

PPLPHARMA

Piramal Pharma Ltd.

₹ 142.00

-0.36%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2102.70

-9.84%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1007.00

+2.32%

COHANCE

Cohance Lifesciences Ltd.

₹ 307.95

-1.28%

SYNGENE

Syngene International Ltd.

₹ 393.10

-0.83%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 655.10

-3.24%

STAR

Strides Pharma Science Ltd.

₹ 969.60

+0.62%

GRANULES

Granules India Ltd.

₹ 610.10

-2.87%

FDC

FDC Ltd.

₹ 334.75

+1.96%

SHILPAMED

Shilpa Medicare Ltd.

₹ 385.50

+2.88%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 842.00

+3.12%

NATCOPHARM

Natco Pharma Ltd.

₹ 1024.00

+2.21%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1572.00

+0.12%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 12408.00

-1.63%

MARKSANS

Marksans Pharma Ltd.

₹ 167.90

-0.08%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7810.00

-0.53%

SANOFI

Sanofi India Ltd.

₹ 3262.00

-0.01%

PGHL

Procter & Gamble Health Ltd.

₹ 4789.00

-0.42%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 603.50

+2.51%

FAQ's on CORONA

What is the current share price of Corona Remedies Ltd.?

As of 2 April 2026 at 10:16 AM, the share price for Corona Remedies Ltd. is ₹ 1500 on the NSE and ₹ 1500 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Corona Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 April 2026, the market cap for Corona Remedies Ltd. is approximately ₹ 9169.1 Cr.

What is the 52-Week High and Low for Corona Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Corona Remedies Ltd. shares was ₹ 1699, and the lowest price was ₹ 1336.6.

Who are the major shareholders of Corona Remedies Ltd.?

Significant shareholdings in Corona Remedies Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Corona Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Corona Remedies Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy